Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung; Epidermal Growth Factor Receptor; Leptomeningeal Metastasis Intervention: Drug: Pemetrexed Sponsor: Taipei Veterans General Hospital, Taiwan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Cancer & Oncology | Carcinoma | Hospitals | Non-Small Cell Lung Cancer | Research | Taiwan Health